Myron Wentz
Founder bij USANA HEALTH SCIENCES, INC.
Vermogen: 382 M $ op 31-03-2024
Actieve functies van Myron Wentz
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
USANA HEALTH SCIENCES, INC. | Director/Board Member | 01-05-2020 | - |
Founder | 01-09-1992 | - | |
Chief Executive Officer | 01-09-1992 | 23-07-2008 | |
Chairman | 01-09-1992 | - |
Loopbaan van Myron Wentz
Eerdere bekende functies van Myron Wentz
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
IMMUNOSYN CORP | Director/Board Member | 14-03-2008 | 20-03-2009 |
Gull Laboratories, Inc.
Gull Laboratories, Inc. Medical SpecialtiesHealth Technology Part of Meridian Bioscience, Inc., Gull Laboratories, Inc. is a private company that specializes in surgical and medical instruments as well as drugs. The company is based in Salt Lake City, UT. The company was founded by Myron W. Wentz. Gull Laboratories was acquired by Meridian Bioscience, Inc. from Fresenius SE & Co. KGaA on November 05, 1998 for $18.04 million. | Chairman | 01-01-1974 | 01-01-1998 |
Founder | 01-01-1974 | 01-01-1998 | |
Sanoviv SA de CV | Founder | 01-01-1998 | - |
Opleiding van Myron Wentz
University of Utah | Doctorate Degree |
North Central College | Undergraduate Degree |
University of North Dakota | Graduate Degree |
Statistieken
Internationaal
Verenigde Staten | 7 |
Mexico | 2 |
Operationeel
Founder | 3 |
Director/Board Member | 2 |
Chairman | 2 |
Sectoraal
Health Technology | 4 |
Consumer Services | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
USANA HEALTH SCIENCES, INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Gull Laboratories, Inc.
Gull Laboratories, Inc. Medical SpecialtiesHealth Technology Part of Meridian Bioscience, Inc., Gull Laboratories, Inc. is a private company that specializes in surgical and medical instruments as well as drugs. The company is based in Salt Lake City, UT. The company was founded by Myron W. Wentz. Gull Laboratories was acquired by Meridian Bioscience, Inc. from Fresenius SE & Co. KGaA on November 05, 1998 for $18.04 million. | Health Technology |
Immunosyn Corp.
Immunosyn Corp. BiotechnologyHealth Technology Immunosyn Corp. is a development stage company. It engages in the marketing, distribution, and sale of a biopharmaceutical drug product SF-1019, which is used for the treatment of various diseases and pathological conditions, including chronic inflammatory demyelinating polyneuropathy, diabetic neuropathy, and diabetic ulcers. The company was founded in August 2006 and is headquartered in San Diego, CA. | Health Technology |
Sanoviv SA de CV |
- Beurs
- Insiders
- Myron Wentz
- Ervaring